Xiaoyan Michelle Zhang - Dec 10, 2021 Form 4 Insider Report for Ikena Oncology, Inc. (IKNA)

Role
Chief Scientific Officer
Signature
/s/ Douglas R. Carlson, as Attorney-in-Fact for Xiaoyan Michelle Zhang
Stock symbol
IKNA
Transactions as of
Dec 10, 2021
Transactions value $
-$12,614
Form type
4
Date filed
12/14/2021, 07:48 PM
Previous filing
Nov 23, 2021
Next filing
Jan 12, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IKNA Common Stock Options Exercise $2.15K +1K +2.25% $2.15 45.5K Dec 10, 2021 Direct
transaction IKNA Common Stock Sale -$14.8K -1K -2.2% $14.76 44.5K Dec 10, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IKNA Stock Option (Right to Buy) Options Exercise $0 -1K -3.78% $0.00 25.5K Dec 10, 2021 Common Stock 1K $2.15 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to this option vested and became exercisable on December 14, 2018, with the remainder vesting in 36 substantially equal monthly installments thereafter.